Portfolio (Quarterly)
Guide ↗
Knott David M Jr
· CIK 0001892770| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SNDX | Syndax Pharmaceutical, Inc. | Healthcare | 422,000.0 | $9.9M | 5.87% | +7K | +1.7% | $23.36 | -14.8% |
| 2 | BBIO | Bridgebio Pharma, Inc. | Healthcare | 90,000.0 | $6.7M | 3.98% | +5K | +5.9% | $74.26 | -8.8% |
| 3 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 1,060,000.0 | $6.1M | 3.66% | +90K | +9.3% | $5.80 | +6.7% |
| 4 | ALKS | Alkermes PLC | Healthcare | 120,000.0 | $4.2M | 2.52% | +25K | +26.3% | $35.36 | +5.6% |
| 5 | COGT | Cogent Biosciences Inc. | Healthcare | 104,000.0 | $4.0M | 2.38% | +2K | +2.0% | $38.49 | -11.8% |
| 6 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 181,000.0 | $3.5M | 2.11% | +36K | +24.8% | $19.56 | -13.1% |
| 7 | AGIO | Agios Pharmaceutical, Inc. | Healthcare | 93,058.0 | $3.1M | 1.87% | +75K | +417.0% | $33.83 | -16.3% |
| 8 | TGTX | TG Therapeutics, Inc. | Healthcare | 90,001.0 | $3.0M | 1.78% | +45K | +100.0% | $33.22 | +19.6% |
| 9 | XBI | SPDR S&P Biotech ETF | — | 15,000.0 | $1.9M | 1.14% | +2K | +15.4% | $127.74 | +4.4% |
| 10 | HELP | Cybin Inc | Healthcare | 350,000.0 | $1.7M | 1.00% | +65K | +22.7% | $4.80 | -7.7% |
| 11 | CNTA | Centessa Pharmaceuticals PLC | Healthcare | 39,000.0 | $1.5M | 0.92% | +35K | +875.0% | $39.72 | +0.2% |
| 12 | RZLT | Rezolute, Inc. | Healthcare | 370,000.0 | $1.1M | 0.67% | +30K | +8.8% | $3.05 | +8.2% |
| 13 | OBIO | Orchestra Biomed Holdings, Inc. | Healthcare | 253,651.0 | $1.1M | 0.64% | +4K | +1.5% | $4.25 | -6.6% |
| 14 | CNTB | Connect Biopharma Holdings Limited | Healthcare | 387,835.0 | $1.0M | 0.60% | +188K | +93.9% | $2.62 | -8.4% |
| 15 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 33,069.0 | $693K | 0.41% | +13K | +65.3% | $20.95 | +10.5% |
| 16 | — | Pelthos Therapeutics, Inc. | — | 21,073.0 | $443K | 0.26% | +2K | +9.3% | $21.01 | — |
| 17 | KURA | Kura Oncology, Inc. | Healthcare | 52,767.0 | $429K | 0.26% | +14K | +34.6% | $8.13 | +28.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
58.3%
Financial Services
21.5%
Communication Services
17.3%
Technology
1.5%
Energy
0.6%
Consumer Defensive
0.3%
Basic Materials
0.2%
Real Estate
0.2%
Consumer Cyclical
0.1%
Industrials
0.1%